| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/22/2014 | CN102026634B Induction of tumor hypoxia for cancer therapy |
| 01/22/2014 | CN102018657B Solid dispersoid containing progestational hormone, preparation method thereof and composite comprising same |
| 01/22/2014 | CN101910153B Pyrimidines as kinase inhibitors |
| 01/22/2014 | CN101906094B Preparation and application of novel antibacterial and anticancer compound and derivative thereof |
| 01/22/2014 | CN101875608B Carveol ester derivative and percutaneous absorption preparation containing same |
| 01/22/2014 | CN101874817B Brucea javanica oil enteric-coated microcapsule and preparation method |
| 01/22/2014 | CN101842369B 2, 3-dihydrobenzo[1, 4] dioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous systeme diseases |
| 01/22/2014 | CN101801362B Methods and compositions for treating disorders |
| 01/22/2014 | CN101772487B Thyroid compounds |
| 01/22/2014 | CN101677569B 2-cyanophenyl fused heterocyclic compounds, and compositions and uses thereof |
| 01/22/2014 | CN101606061B Methods and compositions for detecting receptor ligand mimetics |
| 01/22/2014 | CN101583614B Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 01/22/2014 | CN101547602B Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaceutical use |
| 01/22/2014 | CN101522666B Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy |
| 01/22/2014 | CN101517082B Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity |
| 01/22/2014 | CN101302192B Prodrug forms of ribonucleotide reductase inhibitors 3-AP and 3-AMP |
| 01/22/2014 | CN101048409B Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines |
| 01/21/2014 | US8633324 Denibulin di-hydrochloride |
| 01/21/2014 | US8633322 Alkynyl derivatives useful as DPP-1 inhibitors |
| 01/21/2014 | US8633319 7-(1H-pyrazol-4-yl)-1,6-naphthyridine compounds as Syk inhibitors |
| 01/21/2014 | US8633318 Compounds for treatment or prevention of inflammation, an inflammatory disease, or an immune or an autoimmune disorder |
| 01/21/2014 | US8633317 Crystalline salts of thieno[3,2-c]pyridine kinase inhibitors with improved cpy safety profile |
| 01/21/2014 | US8633313 Heterocyclic compounds and their uses |
| 01/21/2014 | US8633312 Dibenzocycloheptatone derivatives and pharmaceutical agents containing said compounds |
| 01/21/2014 | US8633311 Topical application of porphyrins for killing or preventing the growth of bacteria or fungi on a mammal |
| 01/21/2014 | US8633309 Nucleoside phosphoramidates |
| 01/21/2014 | US8633308 Compounds for preventing or treating viral infections and methods of use thereof |
| 01/21/2014 | US8633306 SiRNA targeting histamine receptor H1 |
| 01/21/2014 | US8633305 Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules |
| 01/21/2014 | US8633303 Heterobifunctional pan-selectin inhibitors |
| 01/21/2014 | US8633277 Methods for forming polymer-drug conjugates |
| 01/21/2014 | US8633252 Use of pterosin compounds for treating diabetes and obesity |
| 01/21/2014 | US8633251 Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use |
| 01/21/2014 | US8633250 Cell repair and regeneration by suramin and related polysulfonated napthylureas |
| 01/21/2014 | US8633249 Adjuvant chemotherapy for anaplastic gliomas |
| 01/21/2014 | US8633248 Parenteral selenomethionine for production of selenium-rich foods |
| 01/21/2014 | US8633247 Method for decreasing cartilage damage in dogs |
| 01/21/2014 | US8633246 Omega-3 fatty acids for osteoarthritis |
| 01/21/2014 | US8633245 PAI-1 inhibitor |
| 01/21/2014 | US8633244 Cosmetic compositions comprising esters based on 2-propylheptanol |
| 01/21/2014 | US8633243 Forms of CDDO methyl ester |
| 01/21/2014 | US8633242 Benzylidene indanones and processes for preparation and use thereof |
| 01/21/2014 | US8633241 Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol |
| 01/21/2014 | US8633240 Paclitaxel trihydrates and methods of making thereof |
| 01/21/2014 | US8633239 Process for the preparation of eletriptan |
| 01/21/2014 | US8633238 Lactams and uses thereof |
| 01/21/2014 | US8633236 Compounds, compositions and methods |
| 01/21/2014 | US8633235 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 01/21/2014 | US8633233 Methods and compositions for treating anxiety |
| 01/21/2014 | US8633232 Compounds, compositions and methods of using same for modulating uric acid levels |
| 01/21/2014 | US8633231 Substituted imidazolones, compositions containing such compounds and methods of use |
| 01/21/2014 | US8633230 Viral hepatitis treatment |
| 01/21/2014 | US8633229 Pharmaceutical composition having dopaminergic activity |
| 01/21/2014 | US8633227 Synthesis and novel salt forms of (R)-3-((E)-pyrrolidin-3-yl)vinyl)-5-tetrahydropyran-4-yloxy)pyridine |
| 01/21/2014 | US8633226 Piperidinyl derivative as a modulator of chemokine receptor activity |
| 01/21/2014 | US8633225 Piperidinium compounds and cosmetic compositions containing them |
| 01/21/2014 | US8633224 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 01/21/2014 | US8633223 Process for preparation of 2-methyl-2′-phenylpropionic acid derivatives and novel intermediate compounds |
| 01/21/2014 | US8633222 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 01/21/2014 | US8633221 Method of enhancing lysosomal α-galactosidase A |
| 01/21/2014 | US8633220 Therapeutic agents for ocular hypertension |
| 01/21/2014 | US8633219 Combination therapy |
| 01/21/2014 | US8633218 8-azabicyclo[3.2.1]oct-2-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/21/2014 | US8633217 Crystal forms of kinase inhibitors |
| 01/21/2014 | US8633216 Imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 01/21/2014 | US8633215 Thienyl-and furanyl-isoquinolinones and methods for using them |
| 01/21/2014 | US8633214 Spiro (piperidine-4,2′-pyrrolidine)-1-(3,5-trifluoromethylphenyl) methylcarboxamides as NK1 tachikynin receptor antagonists |
| 01/21/2014 | US8633213 Crystalline form F of imatinib mesylate |
| 01/21/2014 | US8633212 Inhibitors of beta-secretase |
| 01/21/2014 | US8633211 Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions |
| 01/21/2014 | US8633210 Triazole compounds useful as protein kinase inhibitors |
| 01/21/2014 | US8633209 Hydrobromide salts of a pyrazolylaminoquinazoline |
| 01/21/2014 | US8633208 6-1H-imidazo-quinazoline and quinolines derivatives, new MAO inhibitors and imidazoline receptor ligands |
| 01/21/2014 | US8633207 Quinazoline compounds and methods of use thereof |
| 01/21/2014 | US8633206 Pyrrolo[2,3-D]pyrimidine compounds |
| 01/21/2014 | US8633205 Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein kinases |
| 01/21/2014 | US8633203 Use of pterocarpans as active anti-cellulite ingredients |
| 01/21/2014 | US8633202 Crystalline levofolinic acid and process for its preparation |
| 01/21/2014 | US8633201 Thienopyrimidines having Mnk1/Mnk2 inhibiting activity for pharmaceutical compositions |
| 01/21/2014 | US8633200 Inhibitors of human immunodeficiency virus replication |
| 01/21/2014 | US8633199 Medicine consisting of concomitant use or combination of DPP-IV inhibitor and other diabetic medicine |
| 01/21/2014 | US8633198 Small molecule inhibitors of influenza A RNA-dependent RNA polymerase |
| 01/21/2014 | US8633197 Piperidine/piperazine derivatives |
| 01/21/2014 | US8633196 Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 01/21/2014 | US8633195 Method of inhibiting apolipoprotein-E expression comprising administering a triarylmethyl amine compound |
| 01/21/2014 | US8633194 Pharmaceutical composition of piperazine derivatives |
| 01/21/2014 | US8633193 Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds |
| 01/21/2014 | US8633192 Compositions and uses thereof |
| 01/21/2014 | US8633190 Spirolactam derivatives and uses of same |
| 01/21/2014 | US8633189 Modulators of cystic fibrosis transmembrane conductance regulator |
| 01/21/2014 | US8633188 Aminodihydrothiazine derivatives |
| 01/21/2014 | US8633187 Quinoline derivatives as PI3 kinase inhibitors |
| 01/21/2014 | US8633186 Modulation of chemosensory receptors and ligands associated therewith |
| 01/21/2014 | US8633185 Pyrrolobenzodiazepines |
| 01/21/2014 | US8633184 Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower LDL-C and lower cholesterol |
| 01/21/2014 | US8633183 5-alkynyl-pyrimidines |
| 01/21/2014 | US8633182 Indanyloxyphenylcyclopropanecarboxylic acids |
| 01/21/2014 | US8633181 Treatment of cutaneous hemangioma |
| 01/21/2014 | US8633180 Organic compounds |
| 01/21/2014 | US8633179 Synergistic interaction of NOTCH-1 inhibitors with glucocorticoids |